Sucampo shares rise on expanded constipation drug approval
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
 
 
Sucampo shares rise on expanded constipation drug approval
30 Apr 08, 16:13
Shares of Sucampo Pharmaceuticals Inc. jumped Wednesday after the company said it will receive a $50 million payment from partner Takeda Pharmaceutical Co., now that the Food and Drug Administration expanded approved use of constipation drug Amitiza.
more

 

 
© 2007 nafdacnigeria.org